Compare
Medtronic vs Zimmer Biomet (MDT vs ZBH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Medtronic (MDT) returned +12.6% and Zimmer Biomet (ZBH) +20.6%; so far this year the figures are +6.0% and +17.4%.
Medtronic is the larger company by market value, about 6.5 times the size of Zimmer Biomet.
On trailing earnings, MDT trades at 25.0 times and ZBH at 26.7 times.
Revenue grew +9.8% at MDT and +7.0% at ZBH over the last year.
MDT yields 2.81%. ZBH yields 0.91%.
Data as of the latest close. Not investment advice.
Relative performance
| MDT | ZBH | |
|---|---|---|
| Price | $101.80 | $105.59 |
| 1-day | -2.90% | -1.18% |
| YTD | +5.98% | +17.43% |
| 1 year | +12.61% | +20.61% |
| 3 years | +43.68% | +0.49% |
| Market cap | $130.2B | $20.0B |
| P/E | 25.0 | 26.7 |
| P/S | 3.47 | 2.33 |
| P/B | 2.59 | 1.57 |
| Revenue growth | +9.80% | +7.00% |
| EPS growth | +12.10% | -1.70% |
| Gross margin % | 65.0 | 69.7 |
| Net margin % | 13.9 | 9.0 |
| ROE % | 10.4 | 6.0 |
| Debt / equity | 0.56 | 0.59 |
| FCF yield % | 4.7 | 8.2 |
| Dividend yield % | 2.81 | 0.91 |
| Beta | 0.14 | 0.36 |
| RSI (14) | 63.8 | 64.2 |
| Technical rating |